» Articles » PMID: 17005868

Reconsolidation and Extinction of Conditioned Fear: Inhibition and Potentiation

Overview
Journal J Neurosci
Specialty Neurology
Date 2006 Sep 29
PMID 17005868
Citations 212
Authors
Affiliations
Soon will be listed here.
Abstract

NMDA receptors are important for the acquisition, reconsolidation, and extinction of memories. NMDA receptor antagonists impair these memory processes, whereas the partial agonist D-cycloserine (DCS) potentiates both learning and extinction. Here, we used DCS and the noncompetitive NMDA receptor antagonist (+)-5-methyl-10,11-dihydro-SH-dibenzo[a,d]cyclohepten-5,10-imine maleate (MK-801) to investigate the effects of enhancing and blocking NMDA receptor-mediated glutamatergic transmission on the reconsolidation and extinction of a conditioned fear memory. Either long extinction training or short memory reactivation sessions were used to preferentially engage extinction and reconsolidation processes, respectively. MK-801 blocked extinction to maintain high levels of conditioned freezing, and DCS potentiated extinction to reduce freezing, when they were administered before a long extinction training session. However, the opposite behavioral outcome was observed when the brief memory reactivation session was used: MK-801 administration impaired, whereas DCS increased, freezing, likely reflecting impairment and enhancement of reconsolidation, respectively. Finally, by using localized intracerebral infusions, we showed that the basolateral amygdala is a primary locus of action of systemically administered DCS. Thus, intrabasolateral amygdala DCS potentiated both the extinction and the reconsolidation of fear conditioning, depending on the length of the extinction/memory reactivation session. Therefore, memory reconsolidation can be both disrupted and enhanced, and extinction can be both potentiated and impaired, either to reduce or increase conditioned fear. These results have important implications for the use of reconsolidation blockade and potentiation of extinction as treatment strategies for maladaptive memory disorders.

Citing Articles

Post-retrieval noradrenergic activation impairs subsequent memory depending on cortico-hippocampal reactivation.

Heinbockel H, Leicht G, Wagner A, Schwabe L Elife. 2025; 13.

PMID: 39878439 PMC: 11778928. DOI: 10.7554/eLife.100525.


Examining memory reconsolidation as a mechanism of nitrous oxide's antidepressant action.

Williams E, Taujanskaite U, Kamboj S, Murphy S, Harmer C Neuropsychopharmacology. 2025; 50(4):609-617.

PMID: 39825109 PMC: 11845508. DOI: 10.1038/s41386-024-02049-0.


Time-Dependent Transcriptional Dynamics of Contextual Fear Memory Retrieval Reveals the Function of Dipeptidyl Peptidase 9 in Reconsolidation.

Guo W, Li W, Liu Y, Zhao Y, Xu L, Zhou Q Neurosci Bull. 2024; 41(1):16-32.

PMID: 39621238 PMC: 11748732. DOI: 10.1007/s12264-024-01324-w.


Engrams of Fear Memory Attenuation.

Graff J Adv Neurobiol. 2024; 38:149-161.

PMID: 39008015 DOI: 10.1007/978-3-031-62983-9_9.


Social interaction-induced fear memory reduction: exploring the influence of dopamine and oxytocin receptors on memory updating.

Arellano Perez A, Kautzmann A, de Oliveira Alvares L Transl Psychiatry. 2024; 14(1):242.

PMID: 38844463 PMC: 11156639. DOI: 10.1038/s41398-024-02955-3.


References
1.
Blanchard R, Blanchard D . Crouching as an index of fear. J Comp Physiol Psychol. 1969; 67(3):370-5. DOI: 10.1037/h0026779. View

2.
Quartermain D, Mower J, Rafferty M, HERTING R, Lanthorn T . Acute but not chronic activation of the NMDA-coupled glycine receptor with D-cycloserine facilitates learning and retention. Eur J Pharmacol. 1994; 257(1-2):7-12. DOI: 10.1016/0014-2999(94)90687-4. View

3.
Davis M . Role of NMDA receptors and MAP kinase in the amygdala in extinction of fear: clinical implications for exposure therapy. Eur J Neurosci. 2002; 16(3):395-8. DOI: 10.1046/j.1460-9568.2002.02138.x. View

4.
Fendt M . Injections of the NMDA receptor antagonist aminophosphonopentanoic acid into the lateral nucleus of the amygdala block the expression of fear-potentiated startle and freezing. J Neurosci. 2001; 21(11):4111-5. PMC: 6762710. View

5.
Burns L, Everitt B, Robbins T . Intra-amygdala infusion of the N-methyl-D-aspartate receptor antagonist AP5 impairs acquisition but not performance of discriminated approach to an appetitive CS. Behav Neural Biol. 1994; 61(3):242-50. DOI: 10.1016/s0163-1047(05)80007-x. View